· Weekly signal · MRNA

Moderna Inc (MRNA) momentum broadens with 68.1% four-week surge

The biotechnology stock’s latest weekly close extends a sharp rebound, with strength readings firm but volume evidence not entirely uniform.

Biotechnology lab and market-data screen representing Moderna weekly stock performance.

Moderna Inc (MRNA) closed at 79.76 USD in the latest weekly reading, up 18.6% for the week and 68.1% over four weeks. The move also leaves the stock up 56.5% over twelve weeks.

The weekly price path over 52 weeks shows an active trend, Relative Strength at 79.3 and Market Dynamics confirmation at 0.63. Volume confirmation is mixed: weekly market data shows 43.3 million shares against a 35.8 million 13-week average, while the active-mover screen flags volume at 0.9x.